ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ALRN Aileron Therapeutics Inc

2.87
0.06 (2.14%)
06 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Aileron Therapeutics Inc NASDAQ:ALRN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.06 2.14% 2.87 1.01 4.32 3.15 2.69 2.69 229,536 01:00:00

- Current report filing (8-K)

03/06/2010 3:56pm

Edgar (US Regulatory)


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 3, 2010
American Learning Corporation
(Exact name of registrant as specified in its charter)
         
New York   0-14807   11-2601199
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer Identification No.)
     
One Jericho Plaza, Jericho, New York   11753
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (516) 938-8000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

     
Item 2.02
  Results of Operations and Financial Condition.
 
   
 
  On June 3, 2010, American Learning Corporation (the “Company”) issued a press release announcing its financial results for the year ended March 31, 2010. The press release is attached hereto as Exhibit 99.1. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date of this report, regardless of any general incorporation language in the filing.
 
   
Item 9.01
  Financial Statements and Exhibits.
 
   
 
  (d)     Exhibits.
 
   
Exhibit 99.1
  Press Release of American Learning Corporation, dated June 3, 2010.

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  AMERICAN LEARNING CORPORATION
 
 
Date: June 3, 2010  By:   /s/ Gary Gelman    
    Gary Gelman   
    President and Chief Executive Officer   

 


 

         
EXHIBIT INDEX
     
Exhibit No.   Description
99.1
  Press Release of American Learning Corporation, dated June 3, 2010.

 

1 Year Aileron Therapeutics Chart

1 Year Aileron Therapeutics Chart

1 Month Aileron Therapeutics Chart

1 Month Aileron Therapeutics Chart

Your Recent History

Delayed Upgrade Clock